Premium Nahrungsergänzungsmittel | artgerecht

Quercetin Biotransformation: Metabolism and Effects

Quercetin biotransformation describes how the flavonoid quercetin is metabolized in the body by gut bacteria and liver enzymes into bioavailable metabolites with health-promoting effects.

Regular tips about health Regular tips about health

Things worth knowing about "Quercetin biotransformation"

Quercetin biotransformation describes how the flavonoid quercetin is metabolized in the body by gut bacteria and liver enzymes into bioavailable metabolites with health-promoting effects.

What Is Quercetin Biotransformation?

Quercetin biotransformation refers to the biochemical conversion processes that the plant-derived flavonoid quercetin undergoes after ingestion. Quercetin is one of the most abundant polyphenols in the human diet, found in foods such as onions, apples, capers, and berries. In food, quercetin predominantly exists in glycosidic form – bound to sugar molecules – and must be metabolically converted before it can exert biological effects in the body.

Steps of Biotransformation

Step 1: Intestinal Hydrolysis

In the small intestine, quercetin glycosides (e.g., quercetin-3-glucoside, also known as isoquercitrin) are hydrolyzed by intestinal brush-border enzymes such as lactase-phlorizin hydrolase and by enzymes of the gut microbiota. This cleavage releases the free quercetin aglycone, which can then be passively absorbed across the intestinal wall into the bloodstream.

Step 2: Microbial Metabolism in the Colon

A significant fraction of ingested quercetin escapes absorption in the small intestine and reaches the colon, where it undergoes further transformation by colonic bacteria. This microbial biotransformation produces low-molecular-weight phenolic acids, including:

3,4-Dihydroxybenzoic acid (protocatechuic acid)
3-Hydroxyphenylacetic acid
Phloroglucinol

These degradation products can themselves be biologically active and may be absorbed systemically.

Step 3: Hepatic Conjugation

Following intestinal absorption, quercetin is conjugated in the liver by Phase II enzymes, primarily UDP-glucuronosyltransferases, sulfotransferases, and catechol-O-methyltransferase (COMT). The resulting metabolites include:

Quercetin glucuronides (e.g., quercetin-3-O-glucuronide)
Quercetin sulfates
Isorhamnetin (3'-O-methylated quercetin)
Tamarixetin (4'-O-methylated quercetin)

These conjugated metabolites circulate in the bloodstream and are excreted via the kidneys or returned to the intestine through bile as part of the enterohepatic circulation.

Biological Activity of Quercetin Metabolites

Quercetin biotransformation products are not necessarily inactive. Numerous studies indicate that quercetin conjugates and microbial degradation products may exhibit the following properties:

Antioxidant activity: Neutralization of free radicals and protection against oxidative stress
Anti-inflammatory effects: Inhibition of pro-inflammatory signaling pathways such as NF-κB
Cardioprotective effects: Support of vascular function and endothelial health
Immunomodulatory activity

The biological activity of these metabolites depends strongly on the individual composition of the gut microbiota and on genetic factors influencing the enzymatic activity of hepatic conjugation.

Bioavailability and Influencing Factors

The bioavailability of quercetin is generally considered low and varies considerably depending on:

Chemical form (aglycone vs. glycoside, type of sugar moiety)
Food matrix (e.g., quercetin from onions is better absorbed than from apples)
Individual gut microbiota composition
Co-ingestion of dietary fats (enhances absorption)
Genetic polymorphisms in metabolizing enzymes

Studies indicate that quercetin glycosides often show higher bioavailability than the free aglycone, as glycosides tend to be more water-soluble and stable during intestinal transit.

Clinical Relevance

Understanding quercetin biotransformation is essential for the development of quercetin-based dietary supplements and pharmaceuticals. Formulations such as quercetin phytosome complexes and nanoparticulate delivery systems are being investigated to enhance bioavailability. In addition, potential drug interactions – such as inhibition of cytochrome P450 (CYP) enzymes – are of clinical importance when using quercetin as a supplement.

References

Manach, C. et al. (2004): Polyphenols: food sources and bioavailability. American Journal of Clinical Nutrition, 79(5), 727–747.
Williamson, G. & Clifford, M.N. (2010): Colonic metabolites of berry polyphenols: the missing link to biological activity? British Journal of Nutrition, 104(S3), S48–S66.
Boots, A.W. et al. (2008): Health effects of quercetin: From antioxidant to nutraceutical. European Journal of Pharmacology, 585(2–3), 325–337.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.